Metric Finance
LearnFAQ
LearnFAQ

Learn / ETRA

NASDAQ: ETRA

Electra Therapeutics (ETRA) stock, explained like you're 5

Electra Therapeutics trades on the Nasdaq under the ticker ETRA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 567 million dollars.

Ticker
ETRA
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Small cap, about 567 million dollars

Is Electra Therapeutics a small, medium or large cap company?

No. Electra Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 567 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Electra Therapeutics makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ETRA stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Electra Therapeutics, Inc. (NASDAQ:ETRA) Stock Has Average Target Price of $34.00 According to Brokerages (MarketBeat)
  • Electra Therapeutics, Inc. (ETRA) stock price, news, quote and history (Yahoo Finance UK)
  • Evercore Initiates ELECTRA THERAPEUTICS INC(ETRA.US) With Buy Rating, Announces Target Price $36 (Moomoo)
  • This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday (Benzinga)
  • Total revenue of Electra Therapeutics, Inc. NASDAQ:ETRA (TradingView)

Follow ETRA in your daily brief

Each trading day at 5 PM ET we post what happened to Electra Therapeutics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ETRA

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Electra Therapeutics stock

What does Electra Therapeutics do?

Electra Therapeutics trades on the Nasdaq under the ticker ETRA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 567 million dollars.

What is the ticker symbol for Electra Therapeutics?

Electra Therapeutics trades under the ticker ETRA on the Nasdaq.

What is Electra Therapeutics's market cap?

Electra Therapeutics is a small cap stock with a market cap of about 567 million dollars.

How does Electra Therapeutics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ETRA stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ETRA stock every day?

Add ETRA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ETRA daily

A free brief on Electra Therapeutics and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • BNTX · BioNTech SE
  • EXEL · Exelixis

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • BNTXBioNTech SE
  • EXELExelixis

Compare ETRA: ETRA vs ARGX, ETRA vs RVMD, ETRA vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed